User menu

Haemophilia care in Europe: the ESCHQoL study.

Bibliographic reference Schramm, W ; Gringeri, A ; Ljung, R ; Berger, K ; Crispin, A ; et. al. Haemophilia care in Europe: the ESCHQoL study.. In: Haemophilia, Vol. 18, no.5, p. 729-37 (2012)
Permanent URL http://hdl.handle.net/2078/125221
  1. COLVIN B. T., ASTERMARK J., FISCHER K., GRINGERI A., LASSILA R., SCHRAMM W., THOMAS A., INGERSLEV J., , European principles of haemophilia care, 10.1111/j.1365-2516.2007.01625.x
  2. Gross domestic product (GDP) per capita http://wwwstatsoecdorg
  3. MEMO/08/625, Brussels (2008)
  4. GRINGERI A., LUNDIN B., VON MACKENSEN S., MANTOVANI L., MANNUCCI P. M., , A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study) : Prophylaxis in hemophilia A, 10.1111/j.1538-7836.2011.04214.x
  5. Manco-Johnson Marilyn J., Abshire Thomas C., Shapiro Amy D., Riske Brenda, Hacker Michele R., Kilcoyne Ray, Ingram J. David, Manco-Johnson Michael L., Funk Sharon, Jacobson Linda, Valentino Leonard A., Hoots W. Keith, Buchanan George R., DiMichele Donna, Recht Michael, Brown Deborah, Leissinger Cindy, Bleak Shirley, Cohen Alan, Mathew Prasad, Matsunaga Alison, Medeiros Desiree, Nugent Diane, Thomas Gregory A., Thompson Alexis A., McRedmond Kevin, Soucie J. Michael, Austin Harlan, Evatt Bruce L., Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia, 10.1056/nejmoa067659
  6. SOUCIE J. M., WANG C., SIDDIQI A., KULKARNI R., RECHT M., KONKLE B. A., , The longitudinal effect of body adiposity on joint mobility in young males with Haemophilia A : BODY ADIPOSITY AND HAEMOPHILIA ON JOINT MOBILITY, 10.1111/j.1365-2516.2010.02400.x
  7. STONEBRAKER J. S., BROOKER M., AMAND R. E., FARRUGIA A., SRIVASTAVA A., A study of reported factor VIII use around the world, 10.1111/j.1365-2516.2009.02131.x
  8. Gilbert, Semin Hematol, 30, 3 (1993)
  9. Feldman Brian M., Funk Sharon M., Bergstrom Britt-Marie, Zourikian Nichan, Hilliard Pamela, van der Net Janjaap, Engelbert Raoul, Petrini Pia, van den Berg H. Marijke, Manco-Johnson Marilyn J., Rivard Georges E., Abad Audrey, Blanchette Victor S., Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: Validity of the hemophilia joint health score, 10.1002/acr.20353
  10. BLANCHETTE V. S., Prophylaxis in the haemophilia population : PROPHYLAXIS IN THE HAEMOPHILIA POPULATION, 10.1111/j.1365-2516.2010.02318.x
  11. Schramm, Optimal Clinical Use of Blood Components (2009)
  12. Schramm W Blood safety in the European Community: an initiative for optimal use. Conclusions and Recommendations, Discussion papers, Syllabus Wildbad Kreuth, Germany 1999
  13. O’MAHONY B., NOONE D., GIANGRANDE P. L. F., PRIHODOVA L., Haemophilia care in Europe: a survey of 19 countries : HAEMOPHILIA CARE IN EUROPE, 10.1111/j.1365-2516.2010.02362.x
  14. Lee C. A., Kessler C. M., Varon D., Martinowitz U., Heim M., SZUCS T. D., ÖFFNER A., KRONER B., GIANGRANDE P., BERNTORP E., SCHRAMM W., , Resource utilisation in haemophiliacs treated in Europe: Results from the European Study on Socioeconomic Aspects of Haemophilia Care, 10.1046/j.1365-2516.1998.440498.x
  15. SCHRAMM W., ROYAL S., KRONER B., BERNTORP E., GIANGRANDE P., LUDLAM C., GRINGERI A., BERGER K., SZUCS T., , Clinical outcomes and resource utilization associated with haemophilia care in Europe, 10.1046/j.1365-2516.2002.00580.x
  16. ROYAL S., SCHRAMM W., BERNTORP E., GIANGRANDE P., GRINGERI A., LUDLAM C., KRONER B., SZUCS T., , Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients, 10.1046/j.1365-2516.2002.00581.x
  17. Miners, Sabin, Tolley, Jenkinson, Kind, Lee, Assessing health-related quality-of-life in individuals with haemophilia, 10.1046/j.1365-2516.1999.00347.x
  18. Darby S. C., Kan S. W., Spooner R. J., Giangrande P. L. F., Hill F. G. H., Hay C. R. M., Lee C. A., Ludlam C. A., Williams M., , Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV, 10.1182/blood-2006-10-050435
  19. Plug I., Thirty years of hemophilia treatment in the Netherlands, 1972-2001, 10.1182/blood-2004-05-2008
  20. ROSENDAAL F. R., SMIT C., VAREKAMP I., BRÖCKERVRIENDS A. H. J. T., DIJCK H., SUURMEIJER T. P. B. M., VANDENBROUCKE J. P., BRIËT E., Modern haemophilia treatment: medical improvements and quality of life, 10.1111/j.1365-2796.1990.tb00291.x
  21. DEN UIJL I. E. M., FISCHER K., VAN DER BOM J. G., GROBBEE D. E., ROSENDAAL F. R., PLUG I., Clinical outcome of moderate haemophilia compared with severe and mild haemophilia, 10.1111/j.1365-2516.2008.01837.x
  22. AZNAR J. A., LUCÍA F., ABAD-FRANCH L., JIMÉNEZ-YUSTE V., PÉREZ R., BATLLE J., BALDA I., PARRA R., CORTINA V. R., Haemophilia in Spain, 10.1111/j.1365-2516.2009.02001.x
  23. Gringeri A., Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group, 10.1182/blood-2003-03-0941
  24. Molho, Rolland, Lebrun, Dirat, Courpied, Croughs, Duprat, Sultan, , Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France, 10.1046/j.1365-2516.2000.00358.x
  25. Wenzel, Haemostasis, 28, 106 (1998)
  26. HARTL H. K., REITTER S., EIDHER U., RAMSCHAK H., AY C., PABINGER I., The impact of severe haemophilia on the social status and quality of life among Austrian haemophiliacs, 10.1111/j.1365-2516.2008.01684.x
  27. World, Federation, of, Hemophilia Guidelines for the Management of Hemophilia http://wwwwfhorg 2005